From December 1, 2022 to February 28, 2023, the company has repurchased 91,171 shares, representing 0.33% for KRW 434.14 million. With this, the company has completed the repurchase of 436,008 shares, representing 1.57% for KRW 1,960.45 million under the buyback announced on June 23, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,775 KRW | -0.40% | -0.53% | -8.15% |
2023 | Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023. | CI |
2023 | Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) dropped from S&P Global BMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
-8.15% | 7.63Cr | |
+21.13% | 4.33TCr | |
+25.28% | 2.29TCr | |
+18.48% | 1.54TCr | |
+13.52% | 1.29TCr | |
+43.68% | 1.18TCr | |
-7.79% | 691.1Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+13.13% | 554.99Cr |
- Stock Market
- Equities
- A004310 Stock
- News Hyundai Pharmaceutical Co., Ltd.
- Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.